All In MedTech

Device Trial Radar · NCT03641677

Increasing Lung Transplant Availability Using Normothermic Ex Vivo Lung Perfusion (EVLP) at a Dedicated EVLP Facility

Last checked: Nov 20, 2026Latest source record: Sep 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

174

Actual

Start

Apr 21, 2019

Primary completion

Dec 18, 2023

Study completion Jan 18, 2024

Sponsor

Lead sponsor
Lung Bioengineering Inc.Not on our public-company list
Sponsor type
Industry
First posted
Aug 22, 2018

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to evaluate the safety and effectiveness of the Centralized Lung Evaluation System (CLES) in enabling evaluation of potential donor lungs not otherwise used for transplant into subjects with end stage, survival-limiting lung disease in need of lung transplantation. This will be accomplished by evaluating subject survival at the later of 12 months or hospital discharge post-transplant.

Conditions

  • Lung Diseases

Interventions

  • Centralized Lung Evaluation SystemDevice

    Assessment of allograft lung for transplant suitability

  • Lung TransplantProcedure

    Orthotopic single or double lung transplantation.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. 12 Month Survival or Freedom From MortalityTime frame: 12 Months

Locations

13 sites in 1 country. Site status is shown where the registry gives one.

  • Mayo Clinic Florida

    Jacksonville, Florida

  • Emory University Hospital

    Atlanta, Georgia

  • University of Maryland Medical System

    Baltimore, Maryland

10 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.